ARCHIVES

FDA, NCI Remain At Odds Over Drug approval Guidelines Despite Reconciliation Discussion

This article is from The Cancer Letter archive.

Vol. 13 No. 39 | October 9, 1987

Download PDF Visit The Full Archive

Related Articles

Senate Increases NIH Funding for 2013, Rejects President’s $200+ Million Increase for Program Evaluation Activities

June 22, 2012

Funding opportunties listed.

December 3, 2004

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

NCI Expected of Fund Cancer Education Grants In Fiscal 1986; Final Fate to Be Decided This Week

March 7, 1986

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

June 12, 1992

NCI To Require Reports On Adverse Drug Reactions From Trials

June 10, 1994